Vyant Bio, Inc. Common Stock
VYNT
VYNT was delisted on the 12th of May, 2023.
32 hedge funds and large institutions have $33.3M invested in Vyant Bio, Inc. Common Stock in 2014 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 6 closing their positions.
69% more capital invested
Capital invested by funds: $19.8M → $33.3M (+$13.5M)
50% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 6
38% more call options, than puts
Call options by funds: $83K | Put options by funds: $60K
10% more funds holding
Funds holding: 29 → 32 (+3)
36% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$10.5M |
| 2 |
CM
Castleark Management
Chicago,
Illinois
|
+$3.18M |
| 3 |
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
|
+$2.03M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$691K |
| 5 |
WC
Woodstock Corp
Boston,
Massachusetts
|
+$374K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$1.03M |
| 2 |
SIM
SSI Investment Management
Los Angeles,
California
|
-$676K |
| 3 |
DM
Deerfield Management
New York
|
-$617K |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$471K |
| 5 |
SCM
Sterneck Capital Management
Kansas City,
Missouri
|
-$463K |
VYNT Hedge Fund Activity: Q1 2014 in Review
32 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Vyant Bio, Inc. Common Stock (VYNT) for Q1 2014, worth a combined $33.3M — up 69% from $19.8M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new VYNT positions and 6 closed out — a net gain of 3 holders — while 7 added to existing stakes and 11 trimmed.
The largest buyer was Bank of Montreal, opening a new position worth an estimated $10.5M. The largest seller was Driehaus Capital Management, cutting an estimated $1.03M.
- 32 institutional investors held Vyant Bio, Inc. Common Stock (VYNT) as of Q1 2014, up from 29 in Q4 2013.
- Funds reported $33.3M of Vyant Bio, Inc. Common Stock stock for Q1 2014, up 69% quarter-over-quarter.
- 9 funds opened new Vyant Bio, Inc. Common Stock positions in Q1 2014 and 6 closed out, a net change of +3 holders.
- The largest Vyant Bio, Inc. Common Stock buyer in Q1 2014 was Bank of Montreal, an estimated $10.5M added.
- The largest Vyant Bio, Inc. Common Stock seller in Q1 2014 was Driehaus Capital Management, an estimated $1.03M sold.
Based on aggregated 13F filings for Q1 2014.